Developer docs
API playgroundTry for free, no card

Search company profiles

European Cannabis Holdings (ECH)

Full company profile

uuid000482y

Namestring
European Cannabis Holdings (ECH)
Websiteurl
europeancannabisholdings.com
Company typeenum
Private
Founded yearint
2018
Short descriptiontext

European Cannabis Holdings (ECH) is a London-based medical cannabis investment group founded in 2018, deploying capital across the European medical cannabis sector with a small team of 11–50 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
medical cannabis investment, cannabis venture capital, pharmaceutical investment, cannabis industry holdings, medical cannabis portfolio
Industry2 codes
1Equity Capital Markets Advisory (Equity Issuance Strategy & Readiness)
CodeFSACAAAIPrimaryYes
2Medical Cannabis Dispensaries
CodeCRANAFABPrimaryNo
NAICS code2 codes
  • Other Financial Investment Activities5239
  • All Other Financial Investment Activities52399
SIC code2 codes
  • Security Brokers, Dealers & Flotation Companies6211
  • Finance Services6199
Product category
Medical Cannabis Investment
Social media profiles1 record
Cost components3 values
Personnel, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

European Cannabis Holdings (ECH) is a London-based medical cannabis investment group founded in 2018 that deploys capital into the European medical cannabis sector. The company operates a small team of 11-50 employees and has raised early-stage funding to support its investment activities in the medical cannabis industry.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Medical Cannabis Investment Services
No data
Peers10 records
1Clever Leaves
TypeEmerging player
Description

Vertically integrated medical cannabis operator with cultivation in Colombia and distribution into European markets; comparable to ECH in European medical cannabis go-to-market.

2GW Pharmaceuticals (Jazz Pharmaceuticals)
TypeBroad incumbent
Description

Pioneer in prescription cannabinoid medicines (e.g., Sativex, Epidiolex) and a benchmark for European medical cannabis commercialization — relevant for ECH given shared medical-cannabis and UK/EU orientation.

34Front Ventures
TypeEmerging player
Description

Multi-state U.S. cannabis operator and investor with a capital-light expansion model; comparable to ECH in operating approach, although geographically focused on North America.

4iAnthus Capital Holdings
TypeDirect peer
Description

Cannabis investment and holding company that deployed capital across cultivation, retail and branded products in multiple U.S. states; comparable to ECH as a multi-asset cannabis investment vehicle.

5Canopy Growth Corporation
TypeBroad incumbent
Description

Large-scale global cannabis operator and investor with European medical cannabis exposure through Spectrum Therapeutics; comparable as a capital-markets-driven cannabis platform, though at far larger scale.

6Cannabis Sativa Inc.
TypeDirect peer
Description

Cannabis holding company structured to incubate and invest in cannabis-related brands and operators; closely mirrors ECH's holding/investment model.

7Organic Flower Investments Group
TypeDirect peer
Description

Cannabis-focused investment company deploying capital into emerging cannabis operators and brands; a smaller-scale, more directly comparable peer to ECH in size and investment mandate.

8Privateer Holdings (now Tilray Brands)
TypeBroad incumbent
Description

Originally structured as a cannabis-focused private holding and investment company before evolving into Tilray; one of the closest historical analogues to ECH's investment-group model.

9High Times Holdings
TypeEmerging player
Description

Cannabis-focused holding entity combining media, events and consumer brands; useful comparator for ECH as a cannabis-themed investment platform with brand-driven assets.

10Khiron Life Sciences
TypeDirect peer
Description

Medical cannabis company with significant European operations focused on patient access, prescriptions and clinic networks — directly comparable to ECH's medical-cannabis investment mandate in Europe.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

European Cannabis Holdings (ECH)

Medical Cannabis Investmenteuropeancannabisholdings.com

European Cannabis Holdings (ECH) is a London-based medical cannabis investment group founded in 2018, deploying capital across the European medical cannabis sector with a small team of 11–50 employees.

European Cannabis Holdings (ECH) firmographics

Firmographics
Name
European Cannabis Holdings (ECH)
Website
https://europeancannabisholdings.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
European Cannabis Holdings (ECH) is a London-based medical cannabis investment group founded in 2018, deploying capital across the European medical cannabis sector with a small team of 11–50 employees.
Ownership category
akta.pro rank

European Cannabis Holdings (ECH) industry classification

Industry
Product category
Medical Cannabis Investment
NAICS
Other Financial Investment Activities (5239), All Other Financial Investment Activities (52399)
SIC
Security Brokers, Dealers & Flotation Companies (6211), Finance Services (6199)
akta.pro primary industry
Equity Capital Markets Advisory (Equity Issuance Strategy & Readiness) (FSACAAAI)
akta.pro secondary industry
Medical Cannabis Dispensaries (CRANAFAB)

Keywords

  • Medical cannabis investment
  • Cannabis venture capital
  • Pharmaceutical investment
  • Cannabis industry holdings
  • Medical cannabis portfolio

Where European Cannabis Holdings (ECH) is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

European Cannabis Holdings (ECH) business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others

European Cannabis Holdings (ECH) product offering

Product offering

Core offering

European Cannabis Holdings (ECH) is a London-based medical cannabis investment group founded in 2018 that deploys capital into the European medical cannabis sector. The company operates a small team of 11-50 employees and has raised early-stage funding to support its investment activities in the medical cannabis industry.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Investment Services

Companies that use European Cannabis Holdings (ECH)

Customer profile

Ideal customer profiles1 record

European Cannabis Holdings (ECH) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

European Cannabis Holdings (ECH) competitors and assessment

Company assessment

Emerging players

  • Clever Leaves: Vertically integrated medical cannabis operator with cultivation in Colombia and distribution into European markets; comparable to ECH in European medical cannabis go-to-market.
  • 4Front Ventures: Multi-state U.S. cannabis operator and investor with a capital-light expansion model; comparable to ECH in operating approach, although geographically focused on North America.
  • High Times Holdings: Cannabis-focused holding entity combining media, events and consumer brands; useful comparator for ECH as a cannabis-themed investment platform with brand-driven assets.

Broad incumbents

  • GW Pharmaceuticals (Jazz Pharmaceuticals): Pioneer in prescription cannabinoid medicines (e.g., Sativex, Epidiolex) and a benchmark for European medical cannabis commercialization — relevant for ECH given shared medical-cannabis and UK/EU orientation.
  • Canopy Growth Corporation: Large-scale global cannabis operator and investor with European medical cannabis exposure through Spectrum Therapeutics; comparable as a capital-markets-driven cannabis platform, though at far larger scale.
  • Privateer Holdings (now Tilray Brands): Originally structured as a cannabis-focused private holding and investment company before evolving into Tilray; one of the closest historical analogues to ECH's investment-group model.

Direct peers

  • iAnthus Capital Holdings: Cannabis investment and holding company that deployed capital across cultivation, retail and branded products in multiple U.S. states; comparable to ECH as a multi-asset cannabis investment vehicle.
  • Cannabis Sativa Inc. Cannabis holding company structured to incubate and invest in cannabis-related brands and operators; closely mirrors ECH's holding/investment model.
  • Organic Flower Investments Group: Cannabis-focused investment company deploying capital into emerging cannabis operators and brands; a smaller-scale, more directly comparable peer to ECH in size and investment mandate.
  • Khiron Life Sciences: Medical cannabis company with significant European operations focused on patient access, prescriptions and clinic networks — directly comparable to ECH's medical-cannabis investment mandate in Europe.

Market position

Customer concentration

European Cannabis Holdings (ECH) social profiles

Digital presence

European Cannabis Holdings (ECH) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

European Cannabis Holdings (ECH) leadership team

Management profile

Number of profiles

Profiles1 record

European Cannabis Holdings (ECH) funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

European Cannabis Holdings (ECH) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Cannabis Holdings (ECH)

What does European Cannabis Holdings (ECH) do?

European Cannabis Holdings (ECH) is a London-based medical cannabis investment group founded in 2018 that deploys capital into the European medical cannabis sector. The company operates a small team of 11-50 employees and has raised early-stage funding to support its investment activities in the medical cannabis industry.

When was European Cannabis Holdings (ECH) founded?

European Cannabis Holdings (ECH) was founded in 2018. It employs 11 to 50 people.

Where is European Cannabis Holdings (ECH) based?

European Cannabis Holdings (ECH) is headquartered in London, United Kingdom, in the Europe region.

Who are European Cannabis Holdings (ECH)'s main competitors?

Emerging players on record are Clever Leaves, 4Front Ventures and High Times Holdings. Broad incumbents are GW Pharmaceuticals (Jazz Pharmaceuticals), Canopy Growth Corporation and Privateer Holdings (now Tilray Brands). Direct peers are iAnthus Capital Holdings, Cannabis Sativa Inc., Organic Flower Investments Group and Khiron Life Sciences.

Does European Cannabis Holdings (ECH) have an API?

No public API is recorded for European Cannabis Holdings (ECH).

What industry is European Cannabis Holdings (ECH) in?

European Cannabis Holdings (ECH)'s product category is Medical Cannabis Investment. Its primary akta.pro industry code is FSACAAAI, Equity Capital Markets Advisory (Equity Issuance Strategy & Readiness), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 5239 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireA Global Leader in Cannabis Data & MediaNOBL Group launched in London as a global cannabis data and media platform, consolidating leading industry brands including Prohibition Partners, Atalis, Cannabis Europa, and European Cannabis Week under one portfolio. The group, formerly the Media & Data division of European Cannabis Holdings, brings together a leadership team of industry pioneers with backgrounds in technology, data, media, and capital markets. NOBL aims to accelerate the cannabis industry's growth by providing governments, operators, and investors with comprehensive intelligence, conferences, and consultancy services across multiple jurisdictions.PR NewswireSOL Global annonce la finalisation de son investissement dans European Cannabis HoldingsSOL Global Investments Corp. announced the completion of its investment in European Cannabis Holdings (ECH), increasing its stake to approximately 19.4% of ECH's total issued and outstanding common shares. ECH comprises multiple cannabis-related businesses including Prohibition Partners, Cannabis Europa, CBD brands Nooro and Budca, the Academy of Medical Cannabis, The Medical Cannabis Clinics (a UK-based private clinic chain), and Astral Health. CEO Brady Cobb highlighted ECH's recent milestone of facilitating the first bulk import of medical cannabis to the United Kingdom as an example of pioneering activity that would drive cannabis markets globally.PR NewswireSOL Global anuncia el cierre de la inversión en European Cannabis HoldingsSOL Global Investments Corp announced the closing of its latest investment in European Cannabis Holdings (ECH), bringing its total stake to approximately 19.4% of ECH's issued and outstanding common shares. ECH is a group of cannabis companies in Europe that includes Prohibition Partners, Cannabis Europa, CBD brands Nooro/Budca, The Academy of Medical Cannabis, The Medical Cannabis Clinics, and Astral Health. The investment strengthens SOL Global's leadership position in the European cannabis market and enables ECH to provide strategic and distribution capabilities in Europe for SOL Global's newly formed hemp and CBD subsidiary, Heavenly Rx Ltd.PR NewswireGrow Biotech, ECH e IPS Specials facilitan el primer lote de cannabis medicoGrow Biotech, ECH, and IPS Specials have facilitated the import of the first batch of medical cannabis for multiple patients in the United Kingdom. The shipment includes Bedrocan Flower Afina and Bedica Flower Talea and marks a significant milestone in the establishment of a reliable supply chain for cannabis-based medicines in the UK following regulatory recognition. This development aims to improve patient access to necessary medications and advance the growth of the country's legal cannabis industry.PR NewswireGrow Biotech, ECH and IPS Specials Facilitate First Batch of Medical Cannabis to UK for Multiple PatientsGrow Biotech, European Cannabis Holdings (ECH), and IPS Specials have facilitated the first bulk shipment of medical cannabis to the UK since the Home Office acknowledged its medical benefits. The imported stock, including Bedrocan and Bedica products from the Netherlands, will be delivered directly to patients via a UK pharmacy to treat conditions such as chronic pain and multiple sclerosis. This collaboration establishes an international supply chain cornerstone for the British legal cannabis industry, ensuring compliance with pharmaceutical standards.PR NewswireECH nomme un conseil médical pour aider à mener la révolution du cannabisEuropean Cannabis Holdings (ECH) has appointed a new medical board led by Professor Mike Barnes to guide its strategic direction in the medical cannabis sector. This appointment precedes significant corporate developments and aims to leverage expert expertise in neurology and chronic pain to shape industry standards across Europe. The group intends to use this leadership to advocate for reduced regulatory barriers and expand its portfolio of educational and market intelligence platforms.PR NewswireECH setzt medizinischen Beirat ein, um die Cannabis-Revolution voranzubringenEuropean Cannabis Holdings (ECH) has appointed a new medical advisory board led by Professor Mike Barnes to support upcoming business developments in the medical cannabis sector. The board members, including Dr. David McDowell, Dr. Dani Gordon, and Dr. Leon Barron, will help develop new treatment pathways and strengthen ECH's internal expertise. This strategic move aligns with broader regulatory shifts in Europe, particularly in the UK, Portugal, and Malta, aimed at reducing barriers for medical cannabis treatments.PR NewswireECH Appoints Medical Board to Help Drive Cannabis RevolutionEuropean Cannabis Holdings (ECH) has established a new Medical Board consisting of four experts to guide its developments in the medical cannabis sector. The board will assist ECH in addressing chronic pain and neurological conditions, which are receptive to cannabis-based treatments. This appointment follows significant anticipated corporate developments for ECH and a transformative moment for the European cannabis market driven by increasing demand.